New York State Assembly

Bill No.:  

 
•  Summary 
 
•  Actions 
 
•  Committee Votes 
 
•  Floor Votes 
 
•  Memo 
 
•  Text 
 
•  LFIN 
 
•  Chamber Video/Transcript 

---

S03350 Summary:

BILL NO	S03350
SAME AS	No Same As
SPONSOR	FERNANDEZ
COSPNSR
MLTSPNSR
Amd §3343-a, Pub Health L
Requires practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry.

Go to top    

---

S03350 Actions:

BILL NO	S03350
01/30/2023	REFERRED TO HEALTH
01/03/2024	REFERRED TO HEALTH

Go to top

---

S03350 Committee Votes:

Go to top

---

S03350 Floor Votes:

Go to top

---

S03350 Text:

 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          3350
 
                               2023-2024 Regular Sessions
 
                    IN SENATE
 
                                    January 30, 2023
                                       ___________
 
        Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
          printed to be committed to the Committee on Health
 
        AN  ACT to amend the public health law, in relation to requiring practi-
          tioners who administer naloxone or another overdose reversal agent  to
          a  patient  in the case of a suspected or confirmed overdose to report
          the administration of the agent to the prescription monitoring program
          registry
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section 1. Subdivision 9 of section 3343-a of the public health law is
     2  renumbered  subdivision  10  and a new subdivision 9 is added to read as
     3  follows:
     4    9. Administration of overdose reversal agents.  (a)  Any  practitioner
     5  who administers naloxone or another overdose reversal agent to a patient
     6  in the case of a suspected or confirmed overdose shall report the admin-
     7  istration  of  the agent to the prescription monitoring program registry
     8  within seventy-two hours of administration. Such  report  shall  contain
     9  the  following  information  if  available: (i) the name of the patient;
    10  (ii) the address of the patient; (iii) the date of birth of the patient;
    11  (iv) the time and place of the administration of the agent; and (v)  the
    12  identity of the person who administered the naloxone to the patient.
    13    (b) Any report made pursuant to the terms of this subdivision shall be
    14  considered to be made by the reporter in the course of his or her duties
    15  and shall be directly related to patient care.
    16    § 2. This act shall take effect January 1, 2025.
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD08239-01-3

Go to top